KINGSTONE COS INC (KINS) Fundamental Analysis & Valuation

NASDAQ:KINS • US4967191051

15.37 USD
-0.21 (-1.35%)
At close: Mar 9, 2026
15.37 USD
0 (0%)
After Hours: 3/9/2026, 4:30:02 PM

This KINS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to KINS. KINS was compared to 149 industry peers in the Insurance industry. Both the profitability and the financial health of KINS get a neutral evaluation. Nothing too spectacular is happening here. KINS is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. KINS Profitability Analysis

1.1 Basic Checks

  • In the past year KINS was profitable.
  • KINS had a positive operating cash flow in the past year.
  • KINS had negative earnings in 4 of the past 5 years.
  • In multiple years KINS reported negative operating cash flow during the last 5 years.
KINS Yearly Net Income VS EBIT VS OCF VS FCFKINS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.34%, KINS belongs to the top of the industry, outperforming 91.95% of the companies in the same industry.
  • With an excellent Return On Equity value of 29.21%, KINS belongs to the best of the industry, outperforming 94.63% of the companies in the same industry.
  • KINS's Return On Invested Capital of 7.69% is amongst the best of the industry. KINS outperforms 88.59% of its industry peers.
Industry RankSector Rank
ROA 7.34%
ROE 29.21%
ROIC 7.69%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
KINS Yearly ROA, ROE, ROICKINS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of KINS (15.68%) is better than 79.19% of its industry peers.
  • Looking at the Operating Margin, with a value of 20.17%, KINS is in the better half of the industry, outperforming 74.50% of the companies in the same industry.
Industry RankSector Rank
OM 20.17%
PM (TTM) 15.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KINS Yearly Profit, Operating, Gross MarginsKINS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

4

2. KINS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KINS is destroying value.
  • KINS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KINS Yearly Shares OutstandingKINS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KINS Yearly Total Debt VS Total AssetsKINS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • The Debt to FCF ratio of KINS is 0.06, which is an excellent value as it means it would take KINS, only 0.06 years of fcf income to pay off all of its debts.
  • KINS has a better Debt to FCF ratio (0.06) than 94.63% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that KINS is not too dependend on debt financing.
  • KINS has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. KINS outperforms 83.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.06
Altman-Z N/A
ROIC/WACC0.86
WACC8.95%
KINS Yearly LT Debt VS Equity VS FCFKINS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
KINS Yearly Current Assets VS Current LiabilitesKINS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

3

3. KINS Growth Analysis

3.1 Past

  • KINS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.25%, which is quite impressive.
EPS 1Y (TTM)92.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.16%

3.2 Future

  • KINS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.50% yearly.
  • The Revenue is expected to grow by 11.37% on average over the next years. This is quite good.
EPS Next Y-19.67%
EPS Next 2Y-0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.85%
Revenue Next 2Y11.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

KINS Yearly Revenue VS EstimatesKINS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
KINS Yearly EPS VS EstimatesKINS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

7

4. KINS Valuation Analysis

4.1 Price/Earnings Ratio

  • KINS is valuated cheaply with a Price/Earnings ratio of 5.63.
  • KINS's Price/Earnings ratio is rather cheap when compared to the industry. KINS is cheaper than 80.54% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, KINS is valued rather cheaply.
  • KINS is valuated cheaply with a Price/Forward Earnings ratio of 7.01.
  • Based on the Price/Forward Earnings ratio, KINS is valued a bit cheaper than the industry average as 74.50% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.60, KINS is valued rather cheaply.
Industry RankSector Rank
PE 5.63
Fwd PE 7.01
KINS Price Earnings VS Forward Price EarningsKINS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, KINS is valued a bit cheaper than 77.18% of the companies in the same industry.
  • 81.88% of the companies in the same industry are more expensive than KINS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 4.62
KINS Per share dataKINS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.5%
EPS Next 3YN/A

3

5. KINS Dividend Analysis

5.1 Amount

  • KINS has a Yearly Dividend Yield of 1.28%.
  • Compared to an average industry Dividend Yield of 2.89, KINS has a dividend in line with its industry peers.
  • Compared to the average S&P500 Dividend Yield of 1.82, KINS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.28%

5.2 History

  • KINS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
KINS Yearly Dividends per shareKINS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 2026 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-0.5%
EPS Next 3YN/A
KINS Yearly Income VS Free CF VS DividendKINS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

KINS Fundamentals: All Metrics, Ratios and Statistics

KINGSTONE COS INC

NASDAQ:KINS (3/9/2026, 4:30:02 PM)

After market: 15.37 0 (0%)

15.37

-0.21 (-1.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-05
Earnings (Next)05-06
Inst Owners53.72%
Inst Owner Change5.48%
Ins Owners13.16%
Ins Owner Change3.89%
Market Cap217.49M
Revenue(TTM)N/A
Net Income(TTM)31.45M
Analysts82.86
Price Target21.93 (42.68%)
Short Float %3.88%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield 1.28%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date02-11
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.25%
Min EPS beat(2)0.8%
Max EPS beat(2)33.69%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)7.33%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)17.53%
Revenue beat(4)1
Avg Revenue beat(4)2.52%
Min Revenue beat(4)-2.9%
Max Revenue beat(4)17.53%
Revenue beat(8)4
Avg Revenue beat(8)6.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.99%
Revenue beat(16)8
Avg Revenue beat(16)1.04%
PT rev (1m)-2.27%
PT rev (3m)-2.27%
EPS NQ rev (1m)87.5%
EPS NQ rev (3m)94.44%
EPS NY rev (1m)23.64%
EPS NY rev (3m)23.64%
Revenue NQ rev (1m)-1.71%
Revenue NQ rev (3m)-1.71%
Revenue NY rev (1m)1.95%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE 5.63
Fwd PE 7.01
P/S 1.08
P/FCF 2.96
P/OCF 2.86
P/B 2.02
P/tB 2.03
EV/EBITDA 4.62
EPS(TTM)2.73
EY17.76%
EPS(NY)2.19
Fwd EY14.27%
FCF(TTM)5.18
FCFY33.73%
OCF(TTM)5.37
OCFY34.97%
SpS14.17
BVpS7.61
TBVpS7.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number21.62
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 29.21%
ROCE 9.76%
ROIC 7.69%
ROICexc 8.22%
ROICexgc 10.1%
OM 20.17%
PM (TTM) 15.68%
GM N/A
FCFM 36.58%
ROA(3y)-1.36%
ROA(5y)-1.2%
ROE(3y)-17.5%
ROE(5y)-12.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.06
Debt/EBITDA 0.11
Cap/Depr 107.85%
Cap/Sales 1.34%
Interest Coverage 17.22
Cash Conversion 177.08%
Profit Quality 233.28%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC8.95%
ROIC/WACC0.86
Cap/Depr(3y)98.26%
Cap/Depr(5y)109.6%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.78%
EPS Next Y-19.67%
EPS Next 2Y-0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.16%
Revenue Next Year7.85%
Revenue Next 2Y11.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y746.64%
FCF growth 3Y40.97%
FCF growth 5Y16.49%
OCF growth 1Y968.71%
OCF growth 3Y33.51%
OCF growth 5Y14.18%

KINGSTONE COS INC / KINS FAQ

What is the ChartMill fundamental rating of KINGSTONE COS INC (KINS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to KINS.


Can you provide the valuation status for KINGSTONE COS INC?

ChartMill assigns a valuation rating of 7 / 10 to KINGSTONE COS INC (KINS). This can be considered as Undervalued.


Can you provide the profitability details for KINGSTONE COS INC?

KINGSTONE COS INC (KINS) has a profitability rating of 4 / 10.


What is the valuation of KINGSTONE COS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KINGSTONE COS INC (KINS) is 5.63 and the Price/Book (PB) ratio is 2.02.


Can you provide the expected EPS growth for KINS stock?

The Earnings per Share (EPS) of KINGSTONE COS INC (KINS) is expected to decline by -19.67% in the next year.